LANADELUMAB Pharmacologic Class Indexing
- Class set ID
- c9870b0f-0be1-4015-90b0-bd0d355ee2d4
- Version
- 1
- Effective date
- 20210415
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use TAKHZYRO ® safely and effectively. See full prescribing information for TAKHZYRO ® . TAKHZYRO ® (lanadelumab-flyo) injection, for subcutaneous use Initial U.S. Approval: 2018 | Takeda Pharmaceuticals America, Inc. | 20250228 | 14 |